Johnson, F. K., Bratkovic, D., Byrne, B., Clemens, P. R., Goker-Alpan, O., Geberhiwot, T., … Sathe, S. (2018). First-in-human preliminary pharmacokinetic data on a novel recombinant acid α-glucosidase, ATB200, co-administered with the pharmacological chaperone, AT2221, in patients with late-onset Pompe disease. In Molecular Genetics and Metabolism (Vol. 123, pp. S71–S72). Elsevier BV. https://doi.org/10.1016/j.ymgme.2017.12.177

Johnson, Franklin K., Drago Bratkovic, Barry Byrne, Paula R. Clemens, Ozlem Goker-Alpan, Tarakegn Geberhiwot, Priya Kishnani, et al. “First-in-human preliminary pharmacokinetic data on a novel recombinant acid α-glucosidase, ATB200, co-administered with the pharmacological chaperone, AT2221, in patients with late-onset Pompe disease.” In Molecular Genetics and Metabolism, 123:S71–72. Elsevier BV, 2018. https://doi.org/10.1016/j.ymgme.2017.12.177.

Johnson FK, Bratkovic D, Byrne B, Clemens PR, Goker-Alpan O, Geberhiwot T, et al. First-in-human preliminary pharmacokinetic data on a novel recombinant acid α-glucosidase, ATB200, co-administered with the pharmacological chaperone, AT2221, in patients with late-onset Pompe disease. In: Molecular Genetics and Metabolism. Elsevier BV; 2018. p. S71–2.

Johnson, Franklin K., et al. “First-in-human preliminary pharmacokinetic data on a novel recombinant acid α-glucosidase, ATB200, co-administered with the pharmacological chaperone, AT2221, in patients with late-onset Pompe disease.” Molecular Genetics and Metabolism, vol. 123, no. 2, Elsevier BV, 2018, pp. S71–72. Crossref, doi:10.1016/j.ymgme.2017.12.177.

Johnson FK, Bratkovic D, Byrne B, Clemens PR, Goker-Alpan O, Geberhiwot T, Kishnani P, Ming X, Mozaffar T, Roberts M, Schoser B, Schwenkreis P, Sivakumar K, van der Ploeg A, Sitaraman S, Barth JA, Sathe S. First-in-human preliminary pharmacokinetic data on a novel recombinant acid α-glucosidase, ATB200, co-administered with the pharmacological chaperone, AT2221, in patients with late-onset Pompe disease. Molecular Genetics and Metabolism. Elsevier BV; 2018. p. S71–S72.